Table 1.
Baseline Patient Characteristics
| Variable | XR-NTX | TAU | |
|---|---|---|---|
| (n=153) | (n=155) | P-value | |
| Age, mean (SD) | 44.4 (9.2) | 43.2 (9.4) | 0.33 |
| Male | 84.3% | 85.2% | 0.84 |
| Race | |||
| White/Caucasian | 20.4% | 19.4% | 1.00 |
| Black/African American | 53.3% | 47.7% | 0.36 |
| Hispanic | 24.3% | 29.0% | 0.36 |
| Insurance | |||
| Medicaid | 45.8% | 41.9% | 0.50 |
| Other public | 24.2% | 25.2% | 0.84 |
| Private | 1.3% | 4.5% | 0.10 |
| Cost of self-reported resources used in 90 days prior, mean (SD) | |||
| Non-study opioid-use-disorder therapy | 200 (327) | 361 (1,297) | 0.14 |
| Other non-study medical services | 298 (478) | 256 (419) | 0.42 |
| Criminal justice system | 14,613 (62,064) | 15,255 (63,616) | 0.93 |
| EQ-5D Score, mean (SD) | |||
| Mobility | 1.24 (0.44) | 1.22 (0.42) | 0.65 |
| Self-care | 1.03 (0.16) | 1.05 (0.22) | 0.25 |
| Usual | 1.17 (0.39) | 1.21 (0.44) | 0.44 |
| Pain | 1.56 (0.61) | 1.53 (0.60) | 0.70 |
| Anxiety | 1.49 (0.57) | 1.56 (0.58) | 0.28 |